founder
Joseph Osborne M.D., Ph.D. is the Chief of Molecular Imaging and Therapeutics and a Professor of Radiology at Weill Cornell Medicine. He also serves as an Attending Radiologist at NewYork-Presbyterian/Weill Cornell Medicine.
Dr. Osborne earned his M.D. from Columbia College of Physicians and Surgeons and his Ph.D. in Biochemistry from Columbia’s Graduate School of Arts and Sciences in New York, NY. He completed an internship in Internal Medicine at the Washington Hospital Center in Washington, D.C., followed by residency training in Diagnostic Radiology at Columbia Presbyterian Hospital. He then pursued fellowship training in Nuclear Medicine and completed post-doctoral work at Memorial Sloan Kettering Cancer Center in New York, NY.
As the Director of the Rad Health Equity lab, Dr. Osborne focuses on advancing equitable and cost-effective diagnostics, theranostics, and precision medicine. He was the principal investigator on an NIH Academic Industrial Partnership RO1 grant titled “A new technique to make 68Ga-labeled pharmaceuticals widely available for clinical use” and led the Dean’s Health Disparity Research Award project, “Prostate Cancer Health Impact Program (pCHIP).”
Currently, Dr. Osborne is the Assistant Director for Clinical Trial Participation at the Meyer Cancer Center, where he is working on strengthening the clinical trials infrastructure through the Office of Community Outreach and Engagement.
Recommended
- A Conversation Between Joseph Osborne and Thomas Hope
- Racial/Ethnic Disparities in Genomic Sequencing
- Complex implementation factors demonstrated when evaluating cost-effectiveness and monitoring racial disparities associated with [18F]DCFPyL PET/CT in prostate cancer men
- Association of Black Race With Prostate Cancer–Specific and Other-Cause Mortality
- Access to cardiac PET/CT by sarcoidosis patients and cost-effectiveness analysis of cardiac PET/MR compared to the standard of care
- Social and Demographic Influences of Trust in Cancer Information Among Brooklyn, New York Residents
- Cancer Health Impact Program (CHIP): Identifying Social and Demographic Associations of mHealth Access and Cancer Screening Behaviors Among Brooklyn, New York, Residents
- Disparities in Castration-Resistant Prostate Cancer Trials
- Cyclotron vs generator-produced 68Ga PSMA: a single-institution, prospective clinical trial
Manny Paris is the Director of Radiology Healthcare Administration at the University of Florida College of Medicine in Jacksonville. A healthcare executive with over 20 years of experience, Manny’s background spans radiology, hospital operations, and practice management. His areas of expertise include operations management, healthcare sustainability, molecular imaging, theranostics, strategic planning, innovation, program development, quality management, and stakeholder engagement.
Manny holds a Master’s in History from Rutgers University, a B.S. in Biology and a B.A. in History from William Paterson University, and a degree in Nuclear Medicine Technology from the University of Medicine & Dentistry of New Jersey.
Throughout his career, Manny has demonstrated success in highly competitive markets, particularly in the New York City Metropolitan area. At Memorial Sloan Kettering, he led the Molecular Imaging and Therapeutics Service, partnering with global experts to drive growth and expansion in Nuclear Medicine, PET/CT, PET/MR, Clinical Research, and Theranostics.
During his tenure at New York Presbyterian – HVH, Manny served as Director of Diagnostic Imaging and Interventional Radiology, twice held the role of interim Director of the Cancer Center, and acted as Hospital Administrator on-call.
In addition to his leadership roles, Manny co-founded Rad Health Equity with Dr. Joseph R. Osborne to advocate for improved access to healthcare services including quality radiology services in underserved communities.
Recommended
- Eliminate Inequities – National Cancer Plan
- RSNA Editorial: Imaging Cancer. Alternate CMS Payment Structure for Outpatient Services: A Road to Improving Access to Molecular Imaging in Oncologic Care
- Cancer Epidemiology, Biomarkers & Prevention. Cancer Health Impact Program (CHIP): Identifying Social and Demographic Associations of mHealth Access and Cancer Screening Behaviors Among Brooklyn, New York, Residents
- Racial Disparities in Lung Cancer Screening Among Veterans, 2013 to 2021
- The Patient Experience of Prior Authorization for Cancer Care